This announcement is a separate document:
长春高新：关于子公司聚乙二醇重组人生长激素注射液新适应症上市申请获得国家药监局批准的公告
Changchun Hi-Tech: Announcement on the approval of the subsidiary\'s application for marketing of polyethylene glycol recombinant human growth hormone injections for new indications by the State Drug Administration
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated